Evaxion Biotech A/S (NASDAQ:EVAX) Q3 2025 Earnings Call Transcript November 6, 2025
Operator: Hello, and welcome to the Evaxion Business Update and Third Quarter 2025 Financial Results. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand over to Birgitte Rono, Interim CEO and CSO. Please go ahead.
Birgitte Rono: Thank you. Good morning and good afternoon, and thank you all for joining our Q3 2025 business update and financial results...
